Artificial Intelligence FDA Plans to Use Artificial Intelligence for Regulatory Reviews and Risk Assessments – geneonline.com Google Inc. June 11, 2025 June 11, 2025 FDA Plans to Use Artificial Intelligence for Regulatory Reviews and Risk Assessments geneonline.com
